Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush Refractory Cutaneous T-cell Lymphoma Study
Clinical Trial Protocol ID
10012701

Clinical Trial Investigator Name
Michael Tharp

Clinical Trial Title

Phase IV Randomized Study of Two Dose Levels of Targretin Capsules in Patients with Refractory Cutaneous T-cell Lymphoma



Clinical Trial Protocol Description

Rush Dermatology seeks volunteers with a diagnosis of CTCL (cutaneous T-cell lymphoma) or mycosis fungoides  for a clinical trial testing an oral medication. All office visits and treatments are provided free of charge.



Clinical Trial Eligibility Criteria

You may be eligible to participate in this study if you:

  • Are 18 years of age or older
  • Have a diagnosis of CTCL or mycosis fungoides
  • Have failed treatment with at least one other systemic therapy

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via e-mail, please include the title of the study in your message.





Contact Name Carmen Petrizzo and Danica Uzelac
Contact Phone (312) 563-4001
Contact E-mail clinical_trials@rush.edu
Promotional Information

Clinical Trials Home
Dermatology Trials
Refractory Cutaneous T-cell Lymphoma Study

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois